BD FACSCanto Flow Cytometer Six-Color Analyzer High Sensitivity 10,000 e/s
BD Biosciences
Details
-
CategoryCell Counting / Sorting
-
Dimension24.0in x 36.0in x 25.0in
-
SerialV0050 Model-1
-
Shipping TypeFreight
-
ManufacturingDoes Not Apply
-
Voltage / Hertz120V/220V / 50Hz/60Hz
Description
The BD Biosciences BD FACSCanto Flow Cytometer is a versatile six-color benchtop system designed for efficient, high-sensitivity flow cytometry. This unit, model BD FACSCanto, offers rapid processing of up to 10,000 events per second with minimal sample carryover (<0.1%), making it ideal for rare event analysis. With features like automated compensation, off-line spectral overlap correction, and eight-parameter detection, the system is particularly suited for complex analytical tasks involving rare cell detection and functional studies. Despite some cosmetic wear, this used unit powers on and performs basic tests. Ideal for a range of applications including leucocyte, cell line, and platelet analysis, the BD FACSCanto system simplifies workflow with its advanced design and robust electronics. Note: Computer is not included.
Key Features
- Six-color detection capability
- Processes up to 10,000 events per second
- Minimal sample carryover of less than 0.1%
- Automated compensation with off-line options
- Eight-parameter detection
- Optimized for rare event analysis
Specifications
- Model: BD FACSCanto
- Manufacturer: BD Biosciences
- Detection: Six-color, eight-parameter
- Event Processing: 10,000 events/sec
- Sample Carryover: <0.1%
- Support: Leucocyte, cell lines, platelets, multiplexed bead technologies
Weight
Imperial: 277.2 Pounds
Metric: 125.74 Kilograms
Shipping Dimensions
Imperial: 28.8 lb x 43.2 lb x 30.0 lb
Metric: 73.15 cm x 109.73 cm x 76.2 cm
Harmonized Code
90275000
Harmonized Code Details
Harmonized code 90275000 is for apparatus for physical or chemical analysis, using optical radiations like UV, visible, or IR. This is suitable for the BD FACSCanto Flow Cytometer, which performs fluorescence-based analysis.
Comments 0
There are currently no public comments.